Related Experiment Videos
Defective tumoricidal capacity of macrophages from C3H/HeJ mice
Abstract:
Peritoneal macrophages from C3H/HeN mice treated i.p. with T cell mitogens or viable BCG organisms were cytotoxic to syngeneic tumor cells in vitro. Macrophages from endotoxin-unresponsive C3H/HeJ mice treated with BCG or T cell mitogens, however, were not tumoricidal. Furthermore, unlike cells from C3H/HeN mice, macrophages from C3H/HeJ mice could not be activated for tumor cytotoxicity after in vitro treatment with bacterial endotoxins or with lymphokine-rich supernatants. The subnormal induction of cytotoxic macrophages after in vitro or in vivo treatments in C3H/HeJ mice appears to be a highly selective defect. Macrophage responses (yield, phagocytosis, or peroxidase staining) in inflammatory exudates induced by BCG, T cell mitogens, or heterologous serum in C3H/HeJ or C3H/HeN mice were identical. C3H/HeJ macrophages also responded normally in vitor to chemotactic lymphokines. Thus, C3H/HeJ macrophages possess a profound and selective defect in tumoricidal capacity. This defect was not dependent upon exogenous endotoxins. Defective macrophage cytotoxic responses may reflect non-LPS related functions regulated by the LPS gene.
Insights
Mice with a specific gene defect (C3H/HeJ) show impaired macrophage tumor-killing ability, even when stimulated by common immune activators like BCG or T cell mitogens.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Macrophages are crucial immune cells involved in tumor surveillance and destruction.
- Genetic variations in mice can lead to distinct immune responses.
- Previous studies suggested a role for bacterial endotoxins in activating cytotoxic macrophages.
Purpose of the Study:
- To investigate the tumoricidal capacity of peritoneal macrophages in endotoxin-unresponsive C3H/HeJ mice compared to responsive C3H/HeN mice.
- To determine if the defect in cytotoxic macrophages in C3H/HeJ mice is selective and independent of endotoxin responsiveness.
- To explore the underlying mechanisms of defective macrophage activation.
Main Methods:
- Peritoneal macrophages were isolated from C3H/HeN and C3H/HeJ mice.
- Mice were treated with BCG (Bacillus Calmette-Guérin) or T cell mitogens in vivo and in vitro.
- Macrophage cytotoxicity against syngeneic tumor cells was assessed in vitro.
- Macrophage responses to bacterial endotoxins and lymphokine-rich supernatants were evaluated.
- Macrophage yield, phagocytosis, and peroxidase staining in inflammatory exudates were analyzed.
- Chemotactic responses of macrophages to lymphokines were measured.
Main Results:
- Peritoneal macrophages from C3H/HeN mice treated with BCG or T cell mitogens exhibited cytotoxicity against tumor cells.
- Macrophages from C3H/HeJ mice, despite similar treatments, failed to become tumoricidal.
- C3H/HeJ macrophages could not be activated for tumor cytotoxicity by bacterial endotoxins or lymphokines in vitro.
- This defect in C3H/HeJ mice was highly selective, as other macrophage functions like phagocytosis and chemotaxis remained normal.
- The defective tumoricidal capacity was not dependent on exogenous endotoxins.
Conclusions:
- C3H/HeJ mice possess a profound and selective defect in their macrophages' ability to kill tumor cells.
- This defect is not linked to general endotoxin unresponsiveness but suggests a specific genetic regulation.
- The findings point towards non-lipopolysaccharide (LPS)-related functions regulated by the LPS gene as potentially involved in macrophage tumoricidal capacity.